Achilles Therapeutics (ACHL) Institutional Ownership → weirdest stock market marches on (From DTI) (Ad) Free ACHL Stock Alerts $0.95 +0.03 (+3.27%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Achilles Therapeutics (NASDAQ:ACHL)CurrentInstitutional OwnershipPercentage56.38%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$6.11MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.99M Get ACHL Insider Trade Alerts Want to know when executives and insiders are buying or selling Achilles Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACHL Institutional Buying and Selling by Quarter Ad DTIweirdest stock market marches onFor the last few months, Graham Lindman has been urging investors to ignore virtually every stock on the exchange and only focus on the handful of “Apex Stocks” that produce all the wealth. And he sure seems to be right! Because while we’re in an extremely bullish market, it’s not because most companies are doing that well. It’s because a handful of wealth generating juggernauts are yanking the market to all time highs. That’s why this headline called it the “Weirdest bull market”Graham is hosting a “tell all” workshop about his Apex Indicator here Achilles Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Artal Group S.A.755,375$944K0.0%-66.5%1.894% 5/17/2024 Ikarian Capital LLC1,443,181$1.80M0.2%N/A3.619% 5/15/2024 Baker BROS. Advisors LP1,208,775$1.51M0.0%-42.5%3.031% 5/14/2024 StemPoint Capital LP1,385,750$1.73M0.5%N/A3.475% 5/10/2024 Acadian Asset Management LLC280,929$350K0.0%N/A0.704% 3/7/2024 Fcpm Iii Services B.V.2,390,050$2.13M0.6%N/A5.861% Get the Latest News and Ratings for ACHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/14/2024 Vestal Point Capital LP108,083$96K0.0%N/A0.265% 5/12/2023 Forefront Analytics LLC75,625$72K0.0%+147.7%0.185% 2/14/2023 RA Capital Management L.P.1,607,834$1.45M0.0%-67.9%4.107% 11/14/2022 Point72 Asset Management L.P.2,107,595$4.76M0.0%+18.6%5.383% 11/14/2022 Forefront Analytics LLC32,200$72K0.0%N/A0.082% 8/15/2022 Point72 Asset Management L.P.1,776,744$4.48M0.0%+18.4%4.538% 8/15/2022 Kettle Hill Capital Management LLC242,978$612K0.2%N/A0.621% 2/15/2022 Sender Co & Partners Inc.27,690$139K0.1%N/A0.068% 2/14/2022 Point72 Asset Management L.P.1,000,000$5.01M0.0%+100.0%2.463% 2/11/2022 Syncona Portfolio Ltd11,086,909$55.55M53.1%N/A27.306% 11/15/2021 Point72 Asset Management L.P.500,000$3.90M0.0%N/A1.231% 11/15/2021 Sphera Funds Management LTD.242,500$1.89M0.2%-17.0%0.597% 11/15/2021 AXA S.A.279,454$2.18M0.0%+3.8%0.688% 11/15/2021Farallon Capital Management LLC450,000$3.51M0.0%-54.8%1.108% 11/12/2021 Affinity Asset Advisors LLC100,000$779K0.2%+25.0%0.246% 8/17/2021 Woodline Partners LP77,386$758K0.0%-67.6%0.191% 8/17/2021 Sphera Funds Management LTD.292,194$2.86M0.2%-2.6%0.719% 8/17/2021 Millennium Management LLC196,144$1.92M0.0%-3.3%0.483% 8/16/2021 RA Capital Management L.P.5,014,687$49.09M0.8%+261.1%12.345% 8/16/2021Pinz Capital Management LP16,423$161K0.0%+164.8%0.040% 8/16/2021 Macquarie Group Ltd.40,402$396K0.0%-26.9%0.099% 8/13/2021 Affinity Asset Advisors LLC80,000$783K0.3%+220.0%0.197% 8/13/2021 AXA S.A.269,135$2.64M0.0%N/A0.663% 8/12/2021 JPMorgan Chase & Co.49,405$484K0.0%-92.1%0.122% 8/12/2021 Monashee Investment Management LLC64,697$633K0.1%-48.2%0.159% 8/6/2021 Sei Investments Co.16,220$159K0.0%N/A0.040% 8/3/2021 Peregrine Capital Management LLC225,669$2.21M0.0%-30.0%0.556% 6/10/2021 Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860% 5/19/2021 Squarepoint Ops LLC28,000$463K0.0%N/A0.069% 5/18/2021 Baker BROS. Advisors LP2,591,366$42.89M0.2%N/A6.379% 5/18/2021 Millennium Management LLC202,785$3.36M0.0%N/A0.499% 5/18/2021 RA Capital Management L.P.1,388,888$22.99M0.3%N/A3.419% 5/18/2021 Orbimed Advisors LLC1,584,845$26.23M0.2%N/A3.901% 5/18/2021 Redmile Group LLC2,088,089$34.56M0.5%N/A5.140% Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy.5/18/2021 Alyeska Investment Group L.P.32,230$533K0.0%N/A0.079% 5/18/2021 Boxer Capital LLC1,536,208$25.42M0.9%N/A3.782% 5/18/2021 Citadel Advisors LLC39,253$650K0.0%N/A0.097% 5/17/2021 Deerfield Management Company L.P. Series C800,000$13.24M0.3%N/A1.969% 5/17/2021 Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860% 5/17/2021 Woodline Partners LP238,822$3.95M0.1%N/A0.588% 5/17/2021 Caas Capital Management LP50,000$828K0.0%N/A0.123% 5/17/2021Pinz Capital Management LP6,203$103K0.0%N/A0.015% 5/17/2021 Sphera Funds Management LTD.300,000$4.97M0.4%N/A0.739% 5/14/2021 Monashee Investment Management LLC125,000$2.07M0.3%N/A0.308% 5/12/2021 Pura Vida Investments LLC103,026$1.71M0.0%N/A0.254% 5/12/2021 JPMorgan Chase & Co.625,750$10.36M0.0%N/A1.540% 5/11/2021 Peregrine Capital Management LLC322,261$5.33M0.1%N/A0.793% 5/11/2021 Landscape Capital Management L.L.C.12,540$208K0.0%N/A0.031% 5/7/2021 BlackRock Inc.25,000$413K0.0%N/A0.062% (Data available from 1/1/2016 forward) ACHL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACHL shares? During the previous two years, 11 institutional investors and hedge funds held shares of Achilles Therapeutics. The most heavily invested institutionals were Point72 Asset Management L.P. ($4.76M), Fcpm Iii Services B.V. ($2.13M), Ikarian Capital LLC ($1.80M), StemPoint Capital LP ($1.73M), Baker BROS. Advisors LP ($1.51M), RA Capital Management L.P. ($1.45M), and Artal Group S.A. ($944K).Learn more on ACHL's institutional investors. What percentage of Achilles Therapeutics stock is owned by institutional investors? 56.38% of Achilles Therapeutics stock is owned by institutional investors. Learn more on ACHL's institutional investor holdings. Which institutional investors have been buying Achilles Therapeutics stock? The following institutional investors have purchased Achilles Therapeutics stock in the last 24 months: Fcpm Iii Services B.V. ($2.39M), Ikarian Capital LLC ($1.44M), StemPoint Capital LP ($1.39M), Point72 Asset Management L.P. ($607.60K), Acadian Asset Management LLC ($280.93K), Kettle Hill Capital Management LLC ($242.98K), and Vestal Point Capital LP ($108.08K). How much institutional buying is happening at Achilles Therapeutics? Institutional investors have bought a total of 6,535,866 shares in the last 24 months. This purchase volume represents approximately $8.28M in transactions. Which Achilles Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Achilles Therapeutics stock in the last 24 months: RA Capital Management L.P. ($3.41M), Artal Group S.A. ($1.50M), and Baker BROS. Advisors LP ($894.02K). How much institutional selling is happening at Achilles Therapeutics? Institutional investors have sold a total of 5,800,870 shares in the last 24 months. This volume of shares sold represents approximately $6.06M in transactions. Related Companies: SABS Major Shareholders PLUR Major Shareholders ESLA Major Shareholders INKT Major Shareholders BCLI Major Shareholders QNCX Major Shareholders SRZN Major Shareholders CYTH Major Shareholders OKYO Major Shareholders DYAI Major Shareholders This page (NASDAQ:ACHL) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
